GE Healthcare reports mangaciclanol well tolerated in Phase 2
A website report says mangaciclanol was well tolerated, with no safety concerns, in a Phase 2 study.
A website report says mangaciclanol was well tolerated, with no safety concerns, in a Phase 2 study.